EU Desk 02 of 05
The EU, the UK, Switzerland and the rest of the continent: agency decisions, pricing, factories, enforcement and the companies behind them.
8 stories
CHSwitzerlandMoney
PolyPeptide shareholders elected a five member board chaired by Samsung Biologics CEO John Rim and removed transfer and voting limits, both effective only at settlement of the CHF 44.31 per share offer.
DEGermanyMaking
Sanofi broke ground on October 19, 2026 on a 36,000 square metre insulin API plant at its Frankfurt BioCampus, with full production planned for 2032 once licensed.
GBUnited KingdomRules
The MHRA and West Midlands Police seized more than 12,000 fake retatrutide and tirzepatide pens, valued at about £2 million, from a Birmingham industrial unit on October 14, 2026.
BEBelgiumRules
European-made peptide drugs got a ceiling on what they pay to enter the US.
CHSwitzerlandMaking
One of the largest independent peptide makers adds a building sized for obesity-era volumes.
ITItalyMoney
Novo bought running filling lines instead of waiting years to build them.
DKDenmarkMaking
Novo's oldest large ingredient hub gets its biggest single expansion yet.
DEGermanyMaking
Pens for European patients may come from a German plant instead of crossing the Atlantic.
